ICD-10 Code C83.7A | Burkitt lymphoma, in remission Symptoms, Diagnosis, Billing

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma characterized by rapid tumor growth. It is associated with the translocation of the MYC gene and is often linked to immunocompromised states. The ICD-10 Code C83.7A signifies that the patient is in remission, which is crucial for accurate documentation, billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.

What is ICD-10 Code C83.7A for Burkitt lymphoma, in remission?

ICD-10 Code C83.7A represents Burkitt lymphoma, specifically indicating that the patient is in remission. This code is used when documenting a patient's recovery status following treatment for this aggressive lymphoma. It is essential for accurate clinical documentation and billing, reflecting the patient's current health status and guiding appropriate follow-up care.

ICD-10 Code C83.7A – Clinical Definition and Explanation of Burkitt lymphoma, in remission

Burkitt lymphoma is a type of non-Hodgkin lymphoma that is characterized by rapid cell proliferation and is often associated with the Epstein-Barr virus. The condition requires prompt medical intervention due to its aggressive nature. Remission indicates a significant reduction or absence of disease symptoms, necessitating ongoing monitoring.

Key Clinical Features:

• Rapidly enlarging lymph nodes, often in the abdomen or neck.
• Presence of the MYC gene translocation.
• Commonly affects children and young adults.
• Associated with immunocompromised states, such as HIV.

ICD-10 Code C83.7A for Burkitt lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C83.7A is utilized in SOAP notes to document the patient's remission status, guiding treatment plans and follow-up assessments. It plays a critical role in both acute and chronic care settings, ensuring that healthcare providers have a clear understanding of the patient's current health status.

What Does ICD-10 Code C83.7A for Burkitt lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.7A connects subjective patient reports and objective clinical findings to a formal diagnosis of Burkitt lymphoma in remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C83.7A – Burkitt lymphoma, in remission

Management of Burkitt lymphoma in remission focuses on monitoring and supportive care. Hospitalization may be necessary for patients with complications or those requiring intensive follow-up.

Antibiotic Therapy:

• Not typically indicated unless there is an infection; consider prophylactic antibiotics in immunocompromised patients.
• First-line: Trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis.
• Duration: Typically until immune recovery.

Supportive Care:

• Regular follow-up appointments for monitoring.
• Management of potential late effects of chemotherapy.
• Nutritional support and counseling.

Infection Control:

• Strict hand hygiene practices.
• Isolation precautions if neutropenic.
• Vaccination updates as per guidelines.

How to Document Symptoms of Burkitt lymphoma, in remission (ICD-10 C83.7A) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous chemotherapy treatment.
• Expresses concern about potential recurrence.

Objective:

• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• Physical exam shows no palpable lymphadenopathy.
• Laboratory results indicate normal blood counts.
• Imaging shows no evidence of residual disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Burkitt lymphoma, in remission (ICD-10 Code C83.7A)

Assessment:

• Burkitt lymphoma, in remission (ICD-10 Code C83.7A).
• No evidence of disease recurrence.
• Patient is stable with no acute symptoms.
• Monitor for potential late effects of treatment.

Plan:

• Continue regular follow-up every 3 months.
• Educate patient on signs of recurrence.
• Consider imaging studies as needed for surveillance.
• Reassess treatment plan based on follow-up results.

Treatment & Plan Section for ICD-10 Code C83.7A – Burkitt lymphoma, in remission

• Regular follow-up appointments to monitor for recurrence.
• Patient education on symptoms of relapse.
• Nutritional support and psychosocial counseling.
• Imaging studies as indicated for surveillance.

Using ICD-10 Code C83.7A for Burkitt lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in patient records.
• Use C83.7A in conjunction with relevant treatment codes for billing.
• Document any complications or follow-up care clearly.
• Align treatment plans with clinical guidelines to support billing.

Related ICD-10 Codes Often Used with Burkitt lymphoma, in remission

ICD-10 Code C83.7A in Medical Billing and Insurance for Burkitt lymphoma, in remission

ICD-10 Code C83.7A is critical in medical billing, particularly in hospital and outpatient settings, to reflect the patient's remission status accurately.

Billing Notes:

• Document remission status clearly to support claims.
• Use in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical findings are included in the documentation.

Common CPT Pairings: